Past-Year Use Prevalence of Cannabidiol, Cannabigerol, Cannabinol, and Δ8-Tetrahydrocannabinol Among US Adults.
作者信息
Wilson-Poe Adrianne R, Smith Tristin, Elliott Michael R, Kruger Daniel J, Boehnke Kevin F
机构信息
Dow Neurobiology, Legacy Research Institute, Legacy Health, Portland, Oregon.
Chronic Pain and Fatigue Research Center, Anesthesiology Department, University of Michigan Medical School, Ann Arbor.
出版信息
JAMA Netw Open. 2023 Dec 1;6(12):e2347373. doi: 10.1001/jamanetworkopen.2023.47373.
Abstract
摘要
相似文献
1
Past-Year Use Prevalence of Cannabidiol, Cannabigerol, Cannabinol, and Δ8-Tetrahydrocannabinol Among US Adults.美国成年人中过去一年使用大麻二酚、大麻萜酚、大麻酚和Δ8-四氢大麻酚的流行率。
JAMA Netw Open. 2023 Dec 1;6(12):e2347373. doi: 10.1001/jamanetworkopen.2023.47373.
2
Synthesis and characterization of glucuronides of Cannabinol, cannabidiol, delta9-tetrahydrocannabinol and delta8-tetrahydrocannabinol.大麻酚、大麻二酚、Δ9-四氢大麻酚和Δ8-四氢大麻酚葡糖醛酸苷的合成与表征
Biomed Mass Spectrom. 1977 Jun;4(3):190-6. doi: 10.1002/bms.1200040313.
3
Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.δ-8-四氢大麻酚、大麻二酚和大麻酚的人体皮肤渗透情况。
J Pharm Pharmacol. 2004 Mar;56(3):291-7. doi: 10.1211/0022357022791.
4
Direct Quantitation of Phytocannabinoids by One-Dimensional H qNMR and Two-Dimensional H-H COSY qNMR in Complex Natural Mixtures.一维 H qNMR 和二维 H-H COSY qNMR 在复杂天然混合物中直接定量测定植物大麻素。
Molecules. 2022 May 5;27(9):2965. doi: 10.3390/molecules27092965.
5
Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.
Experientia. 1981 Oct 15;37(10):1090-2. doi: 10.1007/BF02085029.
6
Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.口腔液中的大麻素：限制大麻二酚转化为 Δ9-和 Δ8-四氢大麻酚的潜在来源。
J Anal Toxicol. 2021 Sep 17;45(8):807-812. doi: 10.1093/jat/bkab074.
7
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns.大麻醇和大麻二酚对大鼠摄食模式产生相反的影响。
Psychopharmacology (Berl). 2012 Sep;223(1):117-29. doi: 10.1007/s00213-012-2697-x. Epub 2012 Apr 28.
8
Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS-MS.高效液相色谱-串联质谱法检测口腔液中 Δ8-THC、Δ9-THC、大麻二酚和其他 10 种大麻素及其代谢物的定量分析。
J Anal Toxicol. 2022 Feb 14;46(1):76-88. doi: 10.1093/jat/bkaa184.
9
State Trends of Cannabis Liberalization as a Causal Driver of Increasing Testicular Cancer Rates across the USA.美国大麻合法化趋势对睾丸癌发病率上升的因果驱动作用。
Int J Environ Res Public Health. 2022 Oct 5;19(19):12759. doi: 10.3390/ijerph191912759.
10
Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.某些大麻素对吗啡依赖小鼠中纳洛酮诱发的戒断反应的影响。
Psychopharmacology (Berl). 1976 Sep 29;49(3):267-70. doi: 10.1007/BF00426828.
引用本文的文献
1
Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial.健康成年人中大麻二酚与肝酶水平升高：一项随机临床试验。
JAMA Intern Med. 2025 Jul 7. doi: 10.1001/jamainternmed.2025.2366.
2
Saliva detection of the cannabinoids tetrahydrocannabinolic acid A (THCA-A) and cannabinol (CBN) among nightclub attendees in New York City, 2024.2024年纽约市夜店参与者唾液中大麻素四氢大麻酚酸A（THCA-A）和大麻酚（CBN）的检测
Am J Drug Alcohol Abuse. 2025 Jun 23:1-8. doi: 10.1080/00952990.2025.2515360.
3
Comprehensive mini-review: therapeutic potential of cannabigerol - focus on the cardiovascular system.综述：大麻二酚的治疗潜力——聚焦于心血管系统
Front Pharmacol. 2025 Mar 26;16:1561385. doi: 10.3389/fphar.2025.1561385. eCollection 2025.
4
Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products.衍生致瘾性大麻产品的在线描述与营销差异。
J Psychoactive Drugs. 2025 Mar 25:1-11. doi: 10.1080/02791072.2025.2484376.
5
Cannabidiol prescribing in the United States: An analysis of real-world data.美国的大麻二酚处方：真实世界数据分析
Drug Alcohol Depend Rep. 2024 Nov 22;13:100303. doi: 10.1016/j.dadr.2024.100303. eCollection 2024 Dec.
6
Cannabidiol Use Among Older Adults: Associations with Cannabis Use, Physical and Mental Health, and Other Substance Use.老年人使用大麻二酚：与大麻使用、身心健康及其他物质使用的关联。
Clin Gerontol. 2024 Nov 22:1-13. doi: 10.1080/07317115.2024.2429595.
7
Highs and Lows: A Mixed-Methods Analysis of the Impact of Adult Use Legalization on Medical Cannabis Patients.高潮与低谷：对成人使用大麻合法化对医用大麻患者影响的混合方法分析
J Psychoactive Drugs. 2024 Nov 21:1-10. doi: 10.1080/02791072.2024.2430608.
8
Improving Cannabis Policy Research at a Pivotal Time for Policy Development.在政策制定的关键时期改进大麻政策研究。
Am J Public Health. 2024 Nov;114(S8):S635-S638. doi: 10.2105/AJPH.2024.307799.
9
Maternal Prenatal Cannabis Use and Child Autism Spectrum Disorder.母亲产前大麻使用与儿童自闭症谱系障碍。
JAMA Netw Open. 2024 Oct 1;7(10):e2440301. doi: 10.1001/jamanetworkopen.2024.40301.
10
Derived psychoactive cannabis product perceptions and use among a sample of US young adults.从美国年轻成年人样本中得出的致幻型大麻素产品认知和使用情况。
Addict Behav. 2025 Jan;160:108180. doi: 10.1016/j.addbeh.2024.108180. Epub 2024 Sep 26.
本文引用的文献
1
Delta-8 tetrahydrocannabinol: a scoping review and commentary.德尔塔-8 四氢大麻酚：范围综述和评论。
Addiction. 2023 Jun;118(6):1011-1028. doi: 10.1111/add.16142. Epub 2023 Feb 13.
2
Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.消费者对δ-8-四氢大麻酚的体验：医疗用途、药物替代以及与δ-9-四氢大麻酚的比较
Cannabis Cannabinoid Res. 2023 Feb;8(1):166-173. doi: 10.1089/can.2021.0124. Epub 2021 Nov 19.
3
Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.大麻素二酚优势型大麻制剂患者调查：感知的医疗效果、不良事件和戒断症状。
Cannabis Cannabinoid Res. 2022 Oct;7(5):706-716. doi: 10.1089/can.2021.0058. Epub 2021 Sep 27.
Zotero 插件